308 related articles for article (PubMed ID: 30468828)
1. The Potential of Exosomes From Cow Milk for Oral Delivery.
Betker JL; Angle BM; Graner MW; Anchordoquy TJ
J Pharm Sci; 2019 Apr; 108(4):1496-1505. PubMed ID: 30468828
[TBL] [Abstract][Full Text] [Related]
2. Bovine milk-derived exosomes for drug delivery.
Munagala R; Aqil F; Jeyabalan J; Gupta RC
Cancer Lett; 2016 Feb; 371(1):48-61. PubMed ID: 26604130
[TBL] [Abstract][Full Text] [Related]
3. High-quality milk exosomes as oral drug delivery system.
Zhong J; Xia B; Shan S; Zheng A; Zhang S; Chen J; Liang XJ
Biomaterials; 2021 Oct; 277():121126. PubMed ID: 34544033
[TBL] [Abstract][Full Text] [Related]
4. Curcumin Encapsulated in Milk Exosomes Resists Human Digestion and Possesses Enhanced Intestinal Permeability in Vitro.
Vashisht M; Rani P; Onteru SK; Singh D
Appl Biochem Biotechnol; 2017 Nov; 183(3):993-1007. PubMed ID: 28466459
[TBL] [Abstract][Full Text] [Related]
5. The potential of porcine ex vivo platform for intestinal permeability screening of FcRn-targeted drugs.
Azevedo C; Andersen JT; Traverso G; Sarmento B
Eur J Pharm Biopharm; 2021 May; 162():99-104. PubMed ID: 33771621
[TBL] [Abstract][Full Text] [Related]
6. Transepithelial transport of Fc-targeted nanoparticles by the neonatal fc receptor for oral delivery.
Pridgen EM; Alexis F; Kuo TT; Levy-Nissenbaum E; Karnik R; Blumberg RS; Langer R; Farokhzad OC
Sci Transl Med; 2013 Nov; 5(213):213ra167. PubMed ID: 24285486
[TBL] [Abstract][Full Text] [Related]
7. Oral delivery of anti-MDM2 inhibitor SP141-loaded FcRn-targeted nanoparticles to treat breast cancer and metastasis.
Qin JJ; Wang W; Sarkar S; Zhang R
J Control Release; 2016 Sep; 237():101-14. PubMed ID: 27394681
[TBL] [Abstract][Full Text] [Related]
8. Milk exosomes are bioavailable and distinct microRNA cargos have unique tissue distribution patterns.
Manca S; Upadhyaya B; Mutai E; Desaulniers AT; Cederberg RA; White BR; Zempleni J
Sci Rep; 2018 Jul; 8(1):11321. PubMed ID: 30054561
[TBL] [Abstract][Full Text] [Related]
9. A focus on critical aspects of uptake and transport of milk-derived extracellular vesicles across the Caco-2 intestinal barrier model.
Roerig J; Schiller L; Kalwa H; Hause G; Vissiennon C; Hacker MC; Wölk C; Schulz-Siegmund M
Eur J Pharm Biopharm; 2021 Sep; 166():61-74. PubMed ID: 34077790
[TBL] [Abstract][Full Text] [Related]
10. Milk Exosomes: Next-Generation Agents for Delivery of Anticancer Drugs and Therapeutic Nucleic Acids.
Timofeeva AM; Paramonik AP; Sedykh SS; Nevinsky GA
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373342
[TBL] [Abstract][Full Text] [Related]
11. Milk Exosomes Facilitate Oral Delivery of Drugs against Intestinal Bacterial Infections.
Qu S; Han Y; Liu Y; Zhu J; Acaroz U; Shen J; Zhu K
J Agric Food Chem; 2022 Dec; 70(51):16069-16079. PubMed ID: 36515136
[TBL] [Abstract][Full Text] [Related]
12. The Influence of Nanoparticle Properties on Oral Bioavailability of Drugs.
Wang Y; Pi C; Feng X; Hou Y; Zhao L; Wei Y
Int J Nanomedicine; 2020; 15():6295-6310. PubMed ID: 32943863
[TBL] [Abstract][Full Text] [Related]
13. The Intestinal Transport of Bovine Milk Exosomes Is Mediated by Endocytosis in Human Colon Carcinoma Caco-2 Cells and Rat Small Intestinal IEC-6 Cells.
Wolf T; Baier SR; Zempleni J
J Nutr; 2015 Oct; 145(10):2201-6. PubMed ID: 26269243
[TBL] [Abstract][Full Text] [Related]
14. Milk Exosomes: Perspective Agents for Anticancer Drug Delivery.
Sedykh S; Kuleshova A; Nevinsky G
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32932782
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for oral delivery: targeted nanoparticles with peptidic ligands for oral protein delivery.
Yun Y; Cho YW; Park K
Adv Drug Deliv Rev; 2013 Jun; 65(6):822-32. PubMed ID: 23123292
[TBL] [Abstract][Full Text] [Related]
16. Construction and Evaluation of Liraglutide Delivery System based on Milk Exosomes: A New Idea for Oral Peptide Delivery.
Shi Y; Guo S; Liang Y; Liu L; Wang A; Sun K; Li Y
Curr Pharm Biotechnol; 2022; 23(8):1072-1079. PubMed ID: 34414872
[TBL] [Abstract][Full Text] [Related]
17. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability.
He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L
Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310
[TBL] [Abstract][Full Text] [Related]
18. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
[TBL] [Abstract][Full Text] [Related]
19. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
Cai Z; Wang Y; Zhu LJ; Liu ZQ
Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
[TBL] [Abstract][Full Text] [Related]
20. Yak-milk-derived exosomes promote proliferation of intestinal epithelial cells in an hypoxic environment.
Gao HN; Guo HY; Zhang H; Xie XL; Wen PC; Ren FZ
J Dairy Sci; 2019 Feb; 102(2):985-996. PubMed ID: 30580945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
